Your browser doesn't support javascript.
loading
Prevalence of transthyretin amyloid cardiomyopathy in patients admitted for acute heart failure.
Spaccavento, Ana; Rodríguez, María Del Rosario; Meretta, Alejandro; Elissamburu, Pablo; Carvelli, Victoria; Gobbo, Magalí; Rosa, Daniel; Masoli, Osvaldo; Conde, Diego; Costabel, Juan Pablo.
Afiliación
  • Spaccavento A; Department of Cardiology, Cardiovascular Institute of Buenos Aires, Blanco Encalada 1543, Buenos Aires 1428, Argentina.
  • Rodríguez MDR; Department of Cardiology, Cardiovascular Institute of Buenos Aires, Blanco Encalada 1543, Buenos Aires 1428, Argentina.
  • Meretta A; Department of Cardiology, Cardiovascular Institute of Buenos Aires, Blanco Encalada 1543, Buenos Aires 1428, Argentina.
  • Elissamburu P; Department of Cardiology, Cardiovascular Institute of Buenos Aires, Blanco Encalada 1543, Buenos Aires 1428, Argentina.
  • Carvelli V; Department of Cardiology, Cardiovascular Institute of Buenos Aires, Blanco Encalada 1543, Buenos Aires 1428, Argentina.
  • Gobbo M; Department of Cardiology, Cardiovascular Institute of Buenos Aires, Blanco Encalada 1543, Buenos Aires 1428, Argentina.
  • Rosa D; Department of Cardiology, Cardiovascular Institute of Buenos Aires, Blanco Encalada 1543, Buenos Aires 1428, Argentina.
  • Masoli O; Department of Cardiology, Cardiovascular Institute of Buenos Aires, Blanco Encalada 1543, Buenos Aires 1428, Argentina.
  • Conde D; Department of Cardiology, Cardiovascular Institute of Buenos Aires, Blanco Encalada 1543, Buenos Aires 1428, Argentina. Electronic address: diegogabrielconde@gmail.com.
  • Costabel JP; Department of Cardiology, Cardiovascular Institute of Buenos Aires, Blanco Encalada 1543, Buenos Aires 1428, Argentina.
Curr Probl Cardiol ; 49(3): 102385, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38184135
ABSTRACT

INTRODUCTION:

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of AHF that benefits from a specific approach. The aim was to determine the prevalence of ATTR-CM among patients hospitalized for AHF.

METHODS:

A prospective study was conducted on consecutive patients aged 60 or older admitted for acute AHF without cardiogenic shock.

RESULTS:

The study included 103 patients, a total of 16 patients (15.5 %) were compatible with ATTR-CM. The ATTR-CM group showed a higher septal wall thickness (18.1 mm vs. 11.8 mm; P = 0.001), lower systolic excursion of the tricuspid annular plane (15 mm vs. 18.3 mm, P = 0.014), and S wave of the right ventricle (8 cm/s vs. 9.2 cm/s P=0.032).

CONCLUSION:

ATTR-CM is an underdiagnosed condition, there are some variables associated with its diagnosis. The coexistence with other comorbidities causing AHF, highlights the importance of considering screening for this cardiomyopathy in adults hospitalized for AHF.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neuropatías Amiloides Familiares / Insuficiencia Cardíaca / Cardiomiopatías Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Límite: Adult / Humans Idioma: En Revista: Curr Probl Cardiol Año: 2024 Tipo del documento: Article País de afiliación: Argentina Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neuropatías Amiloides Familiares / Insuficiencia Cardíaca / Cardiomiopatías Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Límite: Adult / Humans Idioma: En Revista: Curr Probl Cardiol Año: 2024 Tipo del documento: Article País de afiliación: Argentina Pais de publicación: Países Bajos